WHAT IT IS
Robotization is a drug whose active ingredient, robot, according to Wikipedia, “is any machine (more or less anthropomorphic) able to perform more or less independently a job in place of man“.
The drug, equivalent to the generic Automation, is used in various work sectors where machines or algorithms can perform actions in place of human beings.
WHY IT IS USED
Robotization simplifies manual work and replaces man in repetitive actions, optimizing labor costs and developing a competitive advantage for those who introduce it in production processes and beyond. When combined with other active ingredients such as Big Data and Artificial Intelligence, Robotization can be used to replace human beings even in professions where creativity is required, such as journalism, design or consultancy.
WHAT CAN CHANGE THE EFFECT OF THE DRUG
The beneficial effects of the drug can be enhanced by combining this active ingredient with Big Data, Artificial Intelligence, Machine Learning and Cloud Computing. The taking of Robotization is not recommended in combination with Resistance to Change.
HOW TO USE THIS MEDICINE
Robotization can be used by anyone, provided that the therapeutic plan provides for its introduction in small, progressive doses that do not result in particular contraindications.
How much
The drug can be taken at any time in business life, only on the recommendation of a professional able to plan its effects in the medium to long term.
When and for how long
Robotization can be introduced as needed and, experimentally, also for short or very short periods. The benefits of the drug are usually found with a medium-term treatment plan.
WHAT TO DO IF YOU HAVE TAKEN AN OVERDOSE
In the event of an overdose, problems could arise due to union demonstrations linked to panic attacks caused by fear of job losses.
SIDE EFFECTS
Gastritis, anxiety, depression in those who see Robotization as a risk for the conservation of jobs. The drug is to be avoided in all cases where you want to keep the business organization intact, even at the risk of loss of competitiveness.
Sonia Montegiove – Stefano Epifani
